Schonfeld Strategic Advisors’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-382,233
| Closed | -$50.4M | – | 2545 |
|
|
2025
Q1 | $50.4M | Buy |
382,233
+361,693
| +1,761% | +$47.7M | 0.3% | 31 |
|
|
2024
Q4 | $1.72M | Sell |
20,540
-197
| -0.9% | -$16.5K | 0.01% | 837 |
|
|
2024
Q3 | $1.52M | Sell |
20,737
-113,717
| -85% | -$8.32M | 0.01% | 882 |
|
|
2024
Q2 | $9.21M | Buy |
134,454
+110,036
| +451% | +$7.54M | 0.06% | 323 |
|
|
2024
Q1 | $1.69M | Sell |
24,418
-141,703
| -85% | -$9.81M | 0.01% | 892 |
|
|
2023
Q4 | $11.9M | Buy |
+166,121
| New | +$11.9M | 0.08% | 273 |
|
|
2022
Q4 | – | Sell |
-32,071
| Closed | -$1.49M | – | 2966 |
|
|
2022
Q3 | $1.49M | Sell |
32,071
-31,130
| -49% | -$1.45M | 0.01% | 1016 |
|
|
2022
Q2 | $3.61M | Sell |
63,201
-34,724
| -35% | -$1.98M | 0.04% | 517 |
|
|
2022
Q1 | $5.99M | Buy |
97,925
+76,210
| +351% | +$4.66M | 0.05% | 358 |
|
|
2021
Q4 | $1.14M | Buy |
+21,715
| New | +$1.14M | 0.01% | 813 |
|
|
2017
Q4 | – | Sell |
-131,980
| Closed | -$2.08M | – | 886 |
|
|
2017
Q3 | $2.08M | Buy |
+131,980
| New | +$2.08M | 0.19% | 154 |
|
|
2017
Q2 | – | Sell |
-30,989
| Closed | -$504K | – | 790 |
|
|
2017
Q1 | $504K | Buy |
+30,989
| New | +$504K | 0.05% | 365 |
|
|
2016
Q3 | – | Sell |
-11,871
| Closed | -$460K | – | 572 |
|
|
2016
Q2 | $460K | Buy |
+11,871
| New | +$460K | 0.1% | 240 |
|